10464055

umls-concept:C0019409, umls-concept:C0020792, umls-concept:C0022663, umls-concept:C0035696, umls-concept:C0078058, umls-concept:C0086418, umls-concept:C0205314, umls-concept:C0205419, umls-concept:C0597298, umls-concept:C0597357, umls-concept:C0679622, umls-concept:C1171892, umls-concept:C1515670

1999-11-19

Vascular endothelial growth factor (VEGF) mediates increased vascular permeability and endothelial mitogenesis, and may orchestrate normal glomerular permselectivity and proteinuria. Distinct isoforms result from differential gene splicing. VEGF binds to two cell surface tyrosine-kinase receptors, KDR (kinase domain region) and Flt-1 (fms-like tyrosine kinase-1). The latter also exists in a soluble form (sFlt), which is inhibitory. We have studied patterns of VEGF-isoform and VEGF-receptor expression in isolated single normal human glomeruli. mRNA from 190 glomeruli (from 20 individuals) was harvested on to magnetic beads, and nested reverse transcription-PCR was performed using primers for the VEGF isoforms and VEGF receptors. Simultaneous nested reverse transcription-PCR for CD45 was conducted in order to exclude leucocyte contamination. Unexpected products were isolated, cloned and sequenced. Multiple patterns of glomerular VEGF mRNA isoform expression were identified. Most frequently (58%), all three common forms were expressed. VEGF(189) (i.e. 189-amino-acid form of VEGF) was expressed in 63%, VEGF(165) in 85% and VEGF(121) in 84% of glomeruli. Two unexpected PCR products were also identified: 18% of glomeruli expressed VEGF(145), and 27% of glomeruli expressed a new truncated VEGF splice variant, VEGF(148), lacking exon 6, the terminal part of exon 7 and exon 8. Multiple patterns of VEGF-receptor expression were also identified, the most common being expression of all three isoforms (28%). Overall, KDR was seen in 59% of glomeruli, Flt-1 in 45% and sFlt in 57%. Thus the expression of VEGF within normal glomeruli is complex and variable, with inter- and intra-individual variation. Furthermore, sFlt appears to be the co-dominant form of VEGF receptor expressed within glomeruli, suggesting that, in healthy individuals, a degree of VEGF autoregulation is the norm. The physiological importance of VEGF(148) remains to be confirmed.

eng

IM

MEDLINE

0143-5221

Print

NLM

303-12

pubmed-meshheading:10464055-Aged, pubmed-meshheading:10464055-Amino Acid Sequence, pubmed-meshheading:10464055-Base Sequence, pubmed-meshheading:10464055-Endothelial Growth Factors, pubmed-meshheading:10464055-Gene Expression, pubmed-meshheading:10464055-Humans, pubmed-meshheading:10464055-Kidney Glomerulus, pubmed-meshheading:10464055-Lymphokines, pubmed-meshheading:10464055-Middle Aged, pubmed-meshheading:10464055-Molecular Sequence Data, pubmed-meshheading:10464055-Protein Isoforms, pubmed-meshheading:10464055-RNA, Messenger, pubmed-meshheading:10464055-RNA Splicing, pubmed-meshheading:10464055-Receptor Protein-Tyrosine Kinases, pubmed-meshheading:10464055-Receptors, Growth Factor, pubmed-meshheading:10464055-Receptors, Mitogen, pubmed-meshheading:10464055-Receptors, Vascular Endothelial Growth Factor, pubmed-meshheading:10464055-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:10464055-Vascular Endothelial Growth Factor A, pubmed-meshheading:10464055-Vascular Endothelial Growth Factors

Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.

Journal Article, Research Support, Non-U.S. Gov't